PH
78
-2
M
31
-2
MLM
60
-4
FRT
46
-4
NOC
50
-7
MOS
38
-12
MTCH
22
-8
FLR
45
-3
BLK
72
-4
FOXA
67
3
PG
48
-2
STI
12
-2
JWN
53
5
AEP
45
-2
MCHP
37
-5
AMGN
44
-6
DG
10
-2
AIV
62
-2
KHC
13
-4
TEL
71
2
PH
78
-2
M
31
-2
MLM
60
-4
FRT
46
-4
NOC
50
-7
MOS
38
-12
MTCH
22
-8
FLR
45
-3
BLK
72
-4
FOXA
67
3
PG
48
-2
STI
12
-2
JWN
53
5
AEP
45
-2
MCHP
37
-5
AMGN
44
-6
DG
10
-2
AIV
62
-2
KHC
13
-4
TEL
71
2
Financhill
Back

Matinas BioPharma Holdings 10K Form

Sell
38

MTNB
Matinas BioPharma Holdings

Last Price:
0.71
Seasonality Move:
10.35%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MTNB News And Ratings

See the #1 stock for the next 7 days that we like better than MTNB

MTNB Financial Statistics

Sales & Book Value

Annual Sales: $1.1M
Cash Flow: $-3.11M
Price / Cash Flow: 0
Annual Sales: $3.81
Price / Book: 0.2

Profitability

EPS (TTM): -5.50000
Net Income (TTM): $-22.91M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Matinas BioPharma Holdings Earnings Forecast

Key Matinas BioPharma Holdings Financial Ratios

  • The Research & Development expenses have been 1,321.99% of Revenue.
  • The Net Earning history of MTNB is -2,093.25% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 5 years.

Matinas BioPharma Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: MTNB
Website: matinasbiopharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MTNB Technical Analysis vs Fundamental Analysis

Sell
38
Matinas BioPharma Holdings (MTNB) is a Sell

Is Matinas BioPharma Holdings a Buy or a Sell?